Skip to main content
GutCited

Galactooligosaccharides (GOS) لـ Irritable Bowel Syndrome (IBS)

B

Reduces IBS symptoms (pain, bloating, flatulence) in dose-dependent manner. 3.5 g/day showed better results than 7 g/day (excess fermentation at higher dose).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dgalactooligosaccharides\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

Reduces IBS symptoms (pain, bloating, flatulence) in dose-dependent manner. 3.5 g/day showed better results than 7 g/day (excess fermentation at higher dose).

Key Study Findings

Review
Interplay of probiotics, prebiotics, synbiotics and postbiotics: a review of their therapeutic potential for gastrointestinal …
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: review of prebiotics, probiotics, synbiotics, postbiotics for gastrointestinal inflammation

Randomized Controlled Trial n=45 12 weeks Double-blind
All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable …
Dose: None مقابل: Sequential FODMAP subgroup reintroduction Outcome: Abdominal pain and bloating severity التأثير: None p=0.007 fructans; p=0.04 GOS

المجتمع المدروس: IBS patients (Rome IV) who improved on FODMAP diet

Randomized Controlled Trial 4 weeks Double-blind
Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results From a Double-Blind, Pilot Randomized …
Dose: None مقابل: Traditional low FODMAP diet Outcome: IBS symptom response التأثير: None None

المجتمع المدروس: IBS-D patients (Rome IV)

Systematic Review
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews …
Dose: None مقابل: Various Outcome: IBS symptom improvement التأثير: Probiotics abdominal pain RR 4.04 (2.36-6.92) None

المجتمع المدروس: Adult IBS patients

Randomized Controlled Trial n=34 8 weeks Single-blind
A randomized trial of inulin for bowel symptoms, depression and quality of life in constipation …
Dose: 9.2 g/day total (4.6 g twice daily) مقابل: Maltodextrin 9.2 g/day placebo Outcome: IBS-SSS score and IBS-QoL score التأثير: IBS-SSS: 267.3→195.8; IBS-QoL: 61.0→77.4 0.026 (IBS-SSS); 0.006 (QoL)

المجتمع المدروس: Adults with constipation-predominant IBS

Other
Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers.
Dose: None مقابل: Standard wholegrain flour products Outcome: FODMAP content reduction in cookies and crackers التأثير: Up to 99.5% FODMAP reduction (wheat malt) None

المجتمع المدروس: Laboratory food science study (no human subjects)

Key Statistics

3

الدراسات

400

المشاركون

Positive

B

التقييم

Referenced Papers

Foods (Basel, Switzerland) 2025 3 اقتباسات
Archivos argentinos de … 2024 3 اقتباسات
Carbohydrate polymers 2022 77 اقتباسات
Frontline gastroenterology 2021 56 اقتباسات
Current opinion in … 2021 6 اقتباسات
Critical reviews in … 2019 35 اقتباسات
Foods (Basel, Switzerland) 2019 21 اقتباسات
The American journal … 2019 15 اقتباسات
Journal of gastroenterology … 2017 181 اقتباسات
International journal of … 2017 146 اقتباسات
Journal of gastroenterology … 2017 32 اقتباسات
Current opinion in … 2017 24 اقتباسات
World journal of … 2016 238 اقتباسات
Scandinavian journal of … 2016 17 اقتباسات
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2016 2 اقتباسات
Journal of neurogastroenterology … 2015 60 اقتباسات
Menopause international 2009 29 اقتباسات
Alimentary pharmacology & … 2006 629 اقتباسات
The British journal … 2001 166 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
2.5-5 g/day
ibssupport:
3.5 g/day (optimal dose; higher doses may increase symptoms)
infantgutsupport:
0.24-0.48 g/100 mL formula (added to infant formula)

الحد الأعلى: Well-tolerated up to 15 g/day; optimal dose appears to be 3.5-5 g/day

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Positive --
None 12 weeks Negative 45
None 4 weeks Mixed --
None -- Positive --
9.2 g/day total (4.6 g twice daily) 8 weeks Positive 34
None -- Positive --
1e9 CFU/day + GOS 10 g/L -- Positive --
None -- Neutral --

أفضل وقت للتناول: With meals; start with lower dose and increase gradually

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Gas and bloating (especially above 5 g/day; dose-response is U-shaped)
  • Flatulence at higher doses
  • Abdominal cramping if dose increased too quickly
  • May worsen symptoms in FODMAP-sensitive individuals

التفاعلات المعروفة

  • Other FODMAPs (cumulative fermentation in sensitive individuals)
  • Lactose-containing products (GOS is derived from lactose; generally safe for lactose-intolerant individuals as GOS itself is lactose-free)

الحد الأقصى المسموح به: Well-tolerated up to 15 g/day; optimal dose appears to be 3.5-5 g/day

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Galactooligosaccharides (GOS) help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 400 participants, there is moderate evidence from clinical studies that Galactooligosaccharides (GOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Galactooligosaccharides (GOS) should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 2.5-5 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Galactooligosaccharides (GOS)?
Reported side effects may include Gas and bloating (especially above 5 g/day; dose-response is U-shaped), Flatulence at higher doses, Abdominal cramping if dose increased too quickly, May worsen symptoms in FODMAP-sensitive individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Galactooligosaccharides (GOS) and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.